Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jerrold Frank Rosenbaum, M.D.

Co-Author

This page shows the publications co-authored by Jerrold Rosenbaum and Joel Pava.
Connection Strength

0.635
  1. Anxiety disorders in major depression. Compr Psychiatry. 2000 Mar-Apr; 41(2):97-102.
    View in: PubMed
    Score: 0.054
  2. Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biol Psychiatry. 1999 Jul 15; 46(2):202-11.
    View in: PubMed
    Score: 0.052
  3. Major depressive subtypes and treatment response. Biol Psychiatry. 1997 Oct 01; 42(7):568-76.
    View in: PubMed
    Score: 0.046
  4. Are dependency and self-criticism risk factors for major depressive disorder? Can J Psychiatry. 1997 Apr; 42(3):291-7.
    View in: PubMed
    Score: 0.044
  5. Eating disorder symptomatology in major depression. J Nerv Ment Dis. 1997 Mar; 185(3):140-4.
    View in: PubMed
    Score: 0.044
  6. Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. Psychosomatics. 1996 Nov-Dec; 37(6):518-22.
    View in: PubMed
    Score: 0.043
  7. Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry. 1996 Oct; 153(10):1308-12.
    View in: PubMed
    Score: 0.043
  8. Gender differences in Axis I comorbidity among depressed outpatients. J Affect Disord. 1996 Jun 05; 38(2-3):129-33.
    View in: PubMed
    Score: 0.042
  9. Cardiovascular risk factors in depression. The role of anxiety and anger. Psychosomatics. 1996 Jan-Feb; 37(1):31-7.
    View in: PubMed
    Score: 0.040
  10. Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose. J Clin Psychiatry. 1995 Feb; 56(2):52-5.
    View in: PubMed
    Score: 0.038
  11. Dysfunctional attitudes in major depression. Changes with pharmacotherapy. J Nerv Ment Dis. 1994 Jan; 182(1):45-9.
    View in: PubMed
    Score: 0.035
  12. Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother Psychosom. 1994; 62(3-4):160-7.
    View in: PubMed
    Score: 0.035
  13. Anger attacks in unipolar depression, Part 2: Neuroendocrine correlates and changes following fluoxetine treatment. Am J Psychiatry. 1993 Aug; 150(8):1164-8.
    View in: PubMed
    Score: 0.034
  14. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet. 2001 Mar 08; 105(2):195-206.
    View in: PubMed
    Score: 0.014
  15. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999 Apr; 60(4):221-5.
    View in: PubMed
    Score: 0.013
  16. Course and treatment of atypical depression. J Clin Psychiatry. 1998; 59 Suppl 18:5-9.
    View in: PubMed
    Score: 0.012
  17. Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications. Psychol Med. 1997 May; 27(3):627-33.
    View in: PubMed
    Score: 0.011
  18. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Biol Psychiatry. 1996 Oct 15; 40(8):691-6.
    View in: PubMed
    Score: 0.011
  19. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 1996 Jun 01; 62(3):213-9.
    View in: PubMed
    Score: 0.010
  20. Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment. Am J Psychiatry. 1993 Aug; 150(8):1158-63.
    View in: PubMed
    Score: 0.009
  21. Anger attacks in depressed outpatients and their response to fluoxetine. Psychopharmacol Bull. 1991; 27(3):275-9.
    View in: PubMed
    Score: 0.007
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.